News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • ASE Technology recommended as a long trade on AI-led packaging demand.
  • LEAP capacity expansion cited as a key upside driver.
  • Strong order momentum supports near-term growth expectations.
  • Multiple expansion projects raise execution risk.
  • EMS margin pressure flagged as a downside risk.
  • Recommended entry price at $41.35 with stop loss at $36.00.
  • Price target $52.00 with a 180-trading-day horizon.

Latest Articles

Booking Holdings Shares Slide After EU Court Rejects eTraveli Challenge

Booking Holdings Shares Slide After EU Court Rejects eTraveli Challenge

Booking Holdings shares fell sharply after the EU General Court in Luxembourg dismissed the company's challenge to the European Commission's 2023 decision blocking its proposed acquisition of eTraveli. The court upheld regulators' findings that the transaction would have reinforced Booking's dominant position in hotel online travel agency markets a…

Marvell Shares Rally After CEO Lifts 2027-28 Revenue Targets

Marvell Shares Rally After CEO Lifts 2027-28 Revenue Targets

Marvell Technology shares jumped in morning trading after CEO Matt Murphy raised the company’s revenue guidance for fiscal 2027 and fiscal 2028, significantly increasing the two-year outlook to about $30 billion. The comments highlighted deeper ties with hyperscaler customers and accelerating demand in Marvell’s AI data center portfolio. Positive t…

UroGen (URGN) Trade Idea - Buy on Momentum: Zusduri Adoption Can Extend Topline Before Jelmyto Patent Cliff

UroGen (URGN) Trade Idea - Buy on Momentum: Zusduri Adoption Can Extend Topline Before Jelmyto Patent Cliff

UroGen's early commercial momentum for Zusduri and the company's deep cash position support a swing trade aimed at capturing continued uptake and multiple re-rating. With Q1 revenue rising to $51 million and a market cap near $2.3 billion, the risk/reward looks favorable for a mid-term move. Key risks include eventual generic pressure on Jelmyto, e…

Poland's Central Bank Keeps Rate at 3.75% Citing Inflation Risks

Poland's Central Bank Keeps Rate at 3.75% Citing Inflation Risks

The National Bank of Poland left its policy rate unchanged at 3.75%, responding to rising commodity and energy costs and a recent uptick in inflation. Incoming data showing annual inflation of 3.4% in August and a fiscal outlook that keeps deficit ratios elevated contributed to a cautious stance from policymakers.

Bank of America Upgrade and Shareholder Returns Propel SK hynix Higher

Bank of America Upgrade and Shareholder Returns Propel SK hynix Higher

SK hynix shares jumped after Bank of America raised its rating to Buy and established a $250 price target, citing accelerating demand for AI-focused memory chips. The move coincides with a substantial shareholder return program and signs of a tightening NAND supply environment, enabling the stock to rally even as major U.S. equity benchmarks slippe…

Ivanhoe Mines Extends Rally After Major Western Forelands Resource Update

Ivanhoe Mines Extends Rally After Major Western Forelands Resource Update

Ivanhoe Mines shares continued to advance, rising 2.6% to C$13.63, as investors process a substantial expansion in reported copper resources at the firm's Western Forelands exploration licences. The update, released before markets opened on September 8, 2026, detailed both Indicated and Inferred Mineral Resources and has prompted renewed investor i…

Poland's Central Bank Keeps Key Rate at 3.75% Citing Inflation Upside

Poland's Central Bank Keeps Key Rate at 3.75% Citing Inflation Upside

The National Bank of Poland left its main interest rate unchanged at 3.75% on Wednesday. The Monetary Policy Council's move matched a Reuters survey of 29 economists. Annual inflation rose to 3.4% in August, approaching the central bank's 1.5% to 3.5% target ceiling. ING Poland's chief economist said the balance of inflation risks has moved higher,…

Merz Condemns AfD Over 'Remigration' Policies, Warns of Economic and Social Strain

Merz Condemns AfD Over 'Remigration' Policies, Warns of Economic and Social Strain

Chancellor Friedrich Merz on Wednesday accused the Alternative for Germany (AfD) of backing Russian interests and promoting anti-migrant policies that he characterised as tantamount to ethnic cleansing. His remarks followed the AfD’s strong electoral showing in Saxony-Anhalt and came as the party defended its platform and rejected Merz’s characteri…

Why Micron’s Pullback Looks Like a Tactical Buy: A Clear Trade Plan

Why Micron’s Pullback Looks Like a Tactical Buy: A Clear Trade Plan

Micron (MU) sold off on headlines and profit-taking, but the company's AI-driven revenue surge, massive free cash flow, and bullish technicals argue the pullback is an entry, not an exit. This trade idea lays out an actionable mid-term (45 trading days) long with entry, stop and target, plus the fundamental and technical rationale backing it and th…

IAEA Board Ends Probe into Syria’s Past Nuclear Activities, Citing Full Cooperation

IAEA Board Ends Probe into Syria’s Past Nuclear Activities, Citing Full Cooperation

The International Atomic Energy Agency’s Board of Governors adopted a resolution concluding that outstanding questions about Syria’s secret nuclear activities under the previous Assad family regime have been settled. The move follows cooperation from Syria’s new authorities and an IAEA report finding it 'very likely' that a 2007 Israeli bombing tar…

BKV Shares Drop Again as Share Registration and Analyst Cuts Weigh

BKV Shares Drop Again as Share Registration and Analyst Cuts Weigh

BKV Corp fell 6.5% in pre-market trading to $25.01, extending a pullback from its 52-week high of $32.81. The decline reflects a near-term selling overhang after the company's Aug. 20 registration of roughly 5.3 million shares for existing holders, coupled with a series of analyst price-target cuts and a soft macro market tone. Natural gas volatili…

Cerebras: Positioning to Win the Inference Bottleneck

Cerebras: Positioning to Win the Inference Bottleneck

Cerebras (CBRS) is the highest-conviction way to play inference-focused AI infrastructure without owning only GPU incumbents. The company shows strong demand visibility (reported $25.4B in remaining performance obligations), high-profile partnerships and fresh data-center wins. At $203.50 today, I view CBRS as a long trade: enter $203.50, target $3…

Rocket Lab Unveils Germanium-Free Solar Cell, Shares Tick Up in Premarket

Rocket Lab Unveils Germanium-Free Solar Cell, Shares Tick Up in Premarket

Rocket Lab Corporation's stock rose modestly in premarket trading after the company introduced IMM Apex, a germanium-free solar cell designed for space use. The new cell delivers a Beginning of Life conversion efficiency of 31.5%, reduces cell mass by 40% versus conventional cells, and is positioned as a drop-in replacement to ease customer integra…

Nutriband CEO, Gareth Sheridan to Attend the Nasdaq Life Sciences Advisory Board (LaB) Biotech Summit

Nutriband CEO, Gareth Sheridan to Attend the Nasdaq Life Sciences Advisory Board (LaB) Biotech Summit

Nutriband Inc. announced that its CEO, Gareth Sheridan, will participate in the Nasdaq LaB Biotech Summit. The company develops AVERSA™, an abuse-deterrent transdermal technology designed to prevent misuse of drugs such as fentanyl while maintaining patient access. Nutriband is focused on advancing its pipeline and leveraging its intellectual prope…